The effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro

Abstract

Purpose: In this study, the antiproliferative and apoptotic effects of sunitinib (SU-11248, Sutent) which is used for targeted therapy was evaluated on HeLa cell line originated from human cervix carcinoma.